Competition to get heated over fentanyl patch market

Daewoong Pharmaceutical and Sandoz Korea are poised to step up their marketing in the fentanyl transdermal therapeutic systems market, which has been so far dominated by Janssen’s Durogenic.

Daewoong is expected to market Nycomed’s Matrifen of five different strengths (12, 25, 50, 75 and 100 µg/hour), fentanyl transdermal matrix patch, slated for release in early September. Matrifen contains...